<DOC>
	<DOCNO>NCT00312442</DOCNO>
	<brief_summary>The aim clinical trial evaluate efficacy safety WST09-mediated vascular-targeted photodynamic therapy ( VTP ) patient localized prostate cancer recurrent external radiation therapy temporary ( High Dose Rate , HDR ) brachytherapy .</brief_summary>
	<brief_title>Phase II/III Study WST09 Prostate Cancer After Radiation Therapy</brief_title>
	<detailed_description>This multicentre , open label , phase II/III , 6-month clinical trial additional follow-up Month 12 , aim determine efficacy tolerability WST09-mediated VTP treatment . This treatment consist I.V . infusion WST09 ( 2 mg/kg ) , combination per-cutaneous interstitial illumination use laser light ( wavelength 763nm ) deliver optical fibre position perineum prostatic lobe . Patients eligible participate study must clinically diagnose positive biopsy prostate ( stage T2b-N0-M0 ) diagnose external radiotherapy temporary brachytherapy ( seed ) , present increase PSA level three consecutive occasion ( least 3 month apart ) post-radiation treatment .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Histologically proven localized prostate cancer receive external radiation therapy ; Patients unwilling unable give inform consent ; Patients receive receive chemotherapy ; Patients previously treat HIFU , cryotherapy , salvage treatment , transurethral resection prostate ( TURP ) ; Patients whose previous radiation therapy cause extensive cystitis and/or proctitis . Patients suspect Disseminated Intravascular Coagulation ( DIC ) . Patients prior history coronary artery disease , angina pectoris , myocardial infarction , coronary angioplasty coronary artery bypass graft , severe valvulopathy , cardiac failure , artrial fibrillation / sustain arrhythmia . Patients whose cardiac status allow general anesthesia . Patients history thromboses thromboembolisms . Patients history stroke transient ischemic attack .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Prostate cancer radiation therapy</keyword>
</DOC>